Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent T Ho

Showing results (141-150 of 227) with videos related to

Pageof 23
Sort By:
Bone Marrow Transplantation|September 8, 2020
Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host diseaseNatasha Kekre, Haesook T Kim, Julia Hofer, et al.
Transplantation and Cellular Therapy|March 21, 2026
Impact of Post-Transplant Cyclophosphamide on the Prognostic Value of HCT-CIAnsh Mehta, Haesook T Kim, Arcita Pramudita, et al.
Blood|December 17, 2015
Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHDAna C Alho, Haesook T Kim, Marie J Chammas, et al.
Blood Advances|September 28, 2021
Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitutionKatie Maurer, Haesook T Kim, Thomas M Kuczmarski, et al.
Blood Advances|April 3, 2019
Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host diseaseJennifer S Whangbo, Haesook T Kim, Sarah Nikiforow, et al.
Blood Advances|April 27, 2022
A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host diseaseJennifer S Whangbo, Sarah Nikiforow, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2016
Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern YearsAreej El-Jawahri, Shuli Li, Joseph H Antin, et al.
Transplantation and Cellular Therapy|September 23, 2025
Expression of HLA-B*35 is Associated With an Increased Risk of CMV Viremia and Clinically Significant CMV Infection following PTCy-Based Hematopoietic Cell TransplantationJessica S Little, Kyle M Hebert, Donna S Neuberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 15, 2018
Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell TransplantationMerve Postalcioglu, Haesook T Kim, Faruk Obut, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocolGregory A Yanik, Mary M Horowitz, Daniel J Weisdorf, et al.
Pageof 23

Showing results (141-150 of 227) with videos related to

Sort By:
Pageof 23
Bone Marrow Transplantation|September 8, 2020
Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host diseaseNatasha Kekre, Haesook T Kim, Julia Hofer, et al.
Transplantation and Cellular Therapy|March 21, 2026
Impact of Post-Transplant Cyclophosphamide on the Prognostic Value of HCT-CIAnsh Mehta, Haesook T Kim, Arcita Pramudita, et al.
Blood|December 17, 2015
Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHDAna C Alho, Haesook T Kim, Marie J Chammas, et al.
Blood Advances|September 28, 2021
Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitutionKatie Maurer, Haesook T Kim, Thomas M Kuczmarski, et al.
Blood Advances|April 3, 2019
Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host diseaseJennifer S Whangbo, Haesook T Kim, Sarah Nikiforow, et al.
Blood Advances|April 27, 2022
A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host diseaseJennifer S Whangbo, Sarah Nikiforow, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2016
Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern YearsAreej El-Jawahri, Shuli Li, Joseph H Antin, et al.
Transplantation and Cellular Therapy|September 23, 2025
Expression of HLA-B*35 is Associated With an Increased Risk of CMV Viremia and Clinically Significant CMV Infection following PTCy-Based Hematopoietic Cell TransplantationJessica S Little, Kyle M Hebert, Donna S Neuberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 15, 2018
Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell TransplantationMerve Postalcioglu, Haesook T Kim, Faruk Obut, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocolGregory A Yanik, Mary M Horowitz, Daniel J Weisdorf, et al.
Pageof 23